AQR Capital Management
FLNA

AQR Capital Management’s Filana Therapeutics FLNA Stock Holding History

AQR Capital Management’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-29,782
Closed -$53.9K – 3571
2025
Q2 		$53.9K Sell
29,782
-50,162
-63% -$89.3K ﹤0.01% 3234
2025
Q1 		$120K Buy
+79,944
New +$202K ﹤0.01% 2982
2022
Q4 		– Sell
-5,132
Closed -$215K – 2267
2022
Q3 		$215K Buy
+5,132
New +$139K ﹤0.01% 2025
2022
Q2 		– Sell
-11,372
Closed -$422K – 2284
2022
Q1 		$422K Sell
11,372
-262
-2% -$11.1K ﹤0.01% 1877
2021
Q4 		$508K Sell
11,634
-26
-0.2% -$1.36K ﹤0.01% 1826
2021
Q3 		$724K Sell
11,660
-5,662
-33% -$473K ﹤0.01% 1718
2021
Q2 		$1.48M Buy
17,322
+200
+1% +$10.7K ﹤0.01% 1388
2021
Q1 		$770K Sell
17,122
-10,775
-39% -$424K ﹤0.01% 1664
2020
Q4 		$190K Sell
27,897
-32,473
-54% -$290K ﹤0.01% 2096
2020
Q3 		$695K Buy
+60,370
New +$272K ﹤0.01% 1595
2015
Q2 		– Sell
-3,571
Closed -$47K – 2253
2015
Q1 		$47K Sell
3,571
-586
-14% -$7.91K ﹤0.01% 2121
2014
Q4 		$59K Sell
4,157
-4,800
-54% -$83.1K ﹤0.01% 2480
2014
Q3 		$245K Buy
8,957
+1,943
+28% +$59K ﹤0.01% 2257
2014
Q2 		$282K Buy
7,014
+1,143
+19% +$42.3K ﹤0.01% 2234
2014
Q1 		$226K Buy
+5,871
New +$207K ﹤0.01% 2386

Other funds holding FLNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

AQR Capital Management's FLNA Position: Q3 2025 in Review

AQR Capital Management sold out of Filana Therapeutics (FLNA) in Q3 2025, closing a stake of 29,782 shares — an estimated $53.9K sold.

AQR Capital Management first reported a position in FLNA in Q1 2014 and held it in 15 quarters. The position peaked at $1.48M in Q2 2021. 103 funds tracked by Wall St. Rank hold FLNA as of Q3 2025.

  • AQR Capital Management reported no remaining Filana Therapeutics position as of Q3 2025 after selling out during the quarter.
  • AQR Capital Management sold 29,782 Filana Therapeutics shares in Q3 2025, an estimated $53.9K.
  • AQR Capital Management first reported a position in Filana Therapeutics in Q1 2014 and held it in 15 quarters.
  • AQR Capital Management's Filana Therapeutics position peaked at $1.48M in Q2 2021.
  • 103 funds tracked by Wall St. Rank held Filana Therapeutics as of Q3 2025.

Based on AQR Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.